CIK 0000034956 · Non-accelerated filer<br>Smaller reporting company
TENAX THERAPEUTICS, INC.
Sign in to watch- Ticker
- TENX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 262593535
- Phone
- 919-855-2100
- Business address
- 101 GLEN LENNOX DRIVE, SUITE 300, CHAPEL HILL, NC, 27517
- Former names
- OXYGEN BIOTHERAPEUTICS, INC., SYNTHETIC BLOOD INTERNATIONAL INC
- D Other Notice of Sales of Unregistered Securities
- 3 Insider Initial Statement of Ownership
- 8-K Event Executive or director change
- 3 Insider Initial Statement of Ownership
- SC 13D Stake Beneficial Ownership Report
- 8-K Event Material agreement · Unregistered share sale · Regulation FD disclosure
- 424B5 Offering Prospectus
- 8-K Event Shareholder vote results
- 4 Derivatives Options or other derivatives
- 8-K Event Delisting notice
- SC 13D/A Stake Beneficial Ownership Report
- 8-K Event Other events
- 4 Open-market buy Director bought 5,000 shares at $0.95 ($4,774)
- SC 13D Stake Beneficial Ownership Report
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 10-Q Report Quarterly Report
Page 21 of 50 · 996 filings